Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation

Proceedings of the National Academy of Sciences of the United States of America
Keiji YoshidaShuh Narumiya

Abstract

Bone remodeling, comprising resorption of existing bone and de novo bone formation, is required for the maintenance of a constant bone mass. Prostaglandin (PG)E2 promotes both bone resorption and bone formation. By infusing PGE2 to mice lacking each of four PGE receptor (EP) subtypes, we have identified EP4 as the receptor that mediates bone formation in response to this agent. Consistently, bone formation was induced in wild-type mice by infusion of an EP4-selective agonist and not agonists specific for other EP subtypes. In culture of bone marrow cells from wild-type mice, PGE2 induced expression of core-binding factor alpha1 (Runx2/Cbfa1) and enhanced formation of mineralized nodules, both of which were absent in the culture of cells from EP4-deficient mice. Furthermore, administration of the EP4 agonist restored bone mass and strength normally lost in rats subjected to ovariectomy or immobilization. Histomorphometric analysis revealed that the EP4 agonist induced significant increases in the volume of cancellous bone, osteoid formation, and the number of osteoblasts in the affected bone of immobilized rats, indicating that activation of EP4 induces de novo bone formation. In addition, osteoclasts were found on the increased...Continue Reading

References

Dec 1, 1987·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·A M ParfittR R Recker
Jul 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·E OgawaY Ito
May 26, 1998·Biochemical and Biophysical Research Communications·E SegiA Ichikawa
Sep 1, 1999·Proceedings of the National Academy of Sciences of the United States of America·H HizakiA Ichikawa
Oct 3, 1999·Physiological Reviews·S NarumiyaF Ushikubi
Dec 22, 1999·Genes & Development·G Karsenty
Mar 7, 2000·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Y SakumaK Nakao
Apr 6, 2000·The Journal of Biological Chemistry·C MiyauraT Suda
Aug 30, 2000·Proceedings of the National Academy of Sciences of the United States of America·Y W ZhangY Ito
Sep 1, 2000·Science·G A Rodan, T J Martin
Feb 15, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy
Jun 16, 2001·Molecular Pharmacology·M MachwateG A Rodan

❮ Previous
Next ❯

Citations

Nov 23, 2006·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·U T IwaniecT J Wronski
Jul 11, 2006·Calcified Tissue International·M P AkhterL C Pan
Mar 10, 2010·Calcified Tissue International·Julie B LitzenbergerChristopher R Jacobs
Jun 27, 2007·International Orthopaedics·M LiV M Paralkar
Oct 10, 2006·Modern Rheumatology·Toshinori SakaiNatsuo Yasui
Mar 9, 2004·Archives of Oral Biology·Maiko OshikawaKoichi Ito
Nov 11, 2003·Life Sciences·John W Regan
Nov 24, 2005·Prostaglandins & Other Lipid Mediators·Kazuo MommaToshio Nakanishi
Nov 16, 2002·Prostaglandins & Other Lipid Mediators·Takuya Kobayashi, Shuh Narumiya
Mar 20, 2003·Bioorganic & Medicinal Chemistry Letters·Xavier BillotRobert N Young
Oct 2, 2003·Prostaglandins & Other Lipid Mediators·Lawrence G Raisz, Florence N Woodiel
Mar 29, 2011·Molecular Pharmaceutics·Yeonju LeeRichard A Reinhardt
Jul 22, 2004·Tissue Engineering·Michelle R Kreke, Aaron S Goldstein
Jan 6, 2010·Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences·Giridhar M ShivaramChristopher R Jacobs
Dec 20, 2011·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Lindsay M CoeLaura R McCabe
Sep 5, 2002·The Journal of Clinical Investigation·Masaki Inada, Stephen M Krane
Aug 6, 2004·Pediatric Research·Hiroki KajinoIkunobu Muramatsu
Dec 2, 2011·Chemical & Pharmaceutical Bulletin·Tohru KambeMasaaki Toda
Sep 21, 2011·Endocrine Journal·Toshio MatsumotoShinsuke Kido
Mar 5, 2008·Journal of Periodontology·Sunao SatoTakashi Takata
Mar 20, 2008·The American Journal of Pathology·Sasanka RamanadhamJohn Turk
Oct 5, 2013·Sports Medicine·Hélder FonsecaJosé Alberto Duarte
Dec 5, 2013·TheScientificWorldJournal·Naroa KajarabilleJulio J Ochoa
Nov 28, 2012·Canadian Journal of Physiology and Pharmacology·Marcel HaversathMarcus Jäger
Feb 2, 2013·Seminars in Immunopathology·Ha-Na LeeYoung-Joon Surh
Oct 27, 2007·Cancer Immunology, Immunotherapy : CII·Sheraz YaqubKjetil Taskén

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.